Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ADH1C | P00326 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL9725961 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SHBGCYP1A2KDM4EEPHX1 | |
| Ether SCHEMBL8824885 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SHBGCYP1A2KDM4EEPHX1 | |
| Biphenyl SCHEMBL6377422 | 0.90 | ALDH1A1 (0.40) | ALDH1A1SHBGCYP1A2KDM4EEPHX1 | |
| Biphenyl SCHEMBL11815560 | 0.88 | TSHR (0.46) | ALDH1A1SHBGEPHX1THRBATM | |
| Biphenyl SCHEMBL10811203 | 0.88 | ALDH1A1 (0.36) | ALDH1A1SHBG | |
| Cyclohexane SCHEMBL11165183 | 0.82 | ALDH1A1 (0.40) | ALDH1A1KDM4EEPHX1THRBATM | |
| SCHEMBL10447633 | 0.81 | ALDH1A1 (0.35) | ALDH1A1CYP1A2 | |
| Biphenyl SCHEMBL3001877 | 0.81 | ALDH1A1 (0.61) | ALDH1A1SHBGCYP1A2ADH1CADH1A | |
| Cyclohexane SCHEMBL8441380 | 0.80 | ALDH1A1 (0.39) | ALDH1A1 | |
| Cyclohexane SCHEMBL8441382 | 0.80 | ALDH1A1 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160368844-A1 | Process for Producing Mixtures of Cyclohexanone and Cyclohexanol | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-12-22 | — | — | US | disclosed |
| EP-3024808-A1 | PROCESS FOR PRODUCING MIXTURES OF CYCLOHEXANONE AND CYCLOHEXANOL | ExxonMobil Chemical Patents Inc. (US) | 2016-06-01 | — | — | EP | disclosed |
| WO-2015013017-A1 | PROCESS FOR PRODUCING MIXTURES OF CYCLOHEXANONE AND CYCLOHEXANOL | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-01-29 | — | — | WO | disclosed |
| US-20110141418-A1 | LIQUID CRYSTAL COMPOUNDS | QINETIQ LIMITED (GB) | 2011-06-16 | — | — | US | disclosed |
| WO-2010012994-A1 | LIQUID CRYSTAL COMPOUNDS | QINETIQ LIMITED (GB) | 2010-02-04 | — | — | WO | disclosed |
| US-5108573-A | Anchor of thio or halo compound to improve adhesion of polymer to metal substrate; high density | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1992-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110141418-A1 | LIQUID CRYSTAL COMPOUNDS | HTR3D, HTR3C, SFXN3 | ALDH1A1 4679/4885SHBG 2347/4885CYP1A2 3757/4885 |
| US-20160368844-A1 | Process for Producing Mixtures of Cyclohexanone and Cyclohexanol | KHK, BCKDK, HYPK | ALDH1A1 4271/4885SHBG 2671/4885CYP1A2 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.